MedTrace Logo

Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2

NCT04610801 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2023-10-16

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of Xylitol plus Grapefruit Seed Extract (Xlear) nasal spray as an adjunct treatment of COVID-19.

Conditions

  • Covid19

Interventions

DRUG

Nasal Spray

Randomized to placebo and Xlear

Sponsors & Collaborators

  • Ferrer Medical Innovations

    collaborator UNKNOWN

  • Xlear, Inc

    collaborator INDUSTRY

  • Larkin Community Hospital

    lead OTHER

Principal Investigators

  • Gustavo Ferrer, MD · Larkin Community Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-08
Primary Completion
2022-06-08
Completion
2022-08-08
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04610801 on ClinicalTrials.gov